RaySearch has entered into a long-term distribution agreement with TMS Sp. Z o.o. in Warsaw, Poland. According to the agreement, TMS assumes full responsibility for the marketing, sales and service of RaySearch’s treatment planning system, RayStation®, in Poland.
TMS is a leading distributor of medical radiation therapy and medical diagnostics systems in Poland. Established in 1994, the company has a strong clinical network and provides sales and support services to centers throughout the country. TMS currently has around 100 employees.
Lukasz Skibinski, TMS shareholder and Advisory Board Member, says: “RayStation is a highly innovative system that gives cancer clinics many new treatment possibilities. We are proud to introduce it to Poland and delighted to have RaySearch as a partner.”
Johan Löf, CEO of RaySearch, says: “This is an exciting market with excellent growth potential, and many centers will benefit from the improved patient care that RayStation makes possible. We have a strong and experienced partner in TMS, and I look forward to a successful cooperation.”
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon-ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.
RaySearch Laboratories AB (publ) is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company is also developing the next-generation oncology information system, RayCare®, which comprises a new product area for RaySearch, and which will be launched in 2017. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the share has been listed on NASDAQ Stockholm since November 2003.
More information about RaySearch is available at www.raysearchlabs.com
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00